0002012879-25-000002.txt : 20251003
0002012879-25-000002.hdr.sgml : 20251003
20251002175150
ACCESSION NUMBER: 0002012879-25-000002
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering
ITEM INFORMATION: Investment Company Act Section 3(c)
ITEM INFORMATION: Section 3(c)(1)
ITEM INFORMATION: Section 3(c)(7)
FILED AS OF DATE: 20251003
DATE AS OF CHANGE: 20251002
EFFECTIVENESS DATE: 20251003
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: SOSV IRELAND BIOMANUFACTURING FUND LP
CENTRAL INDEX KEY: 0002012879
ORGANIZATION NAME:
EIN: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-508494
FILM NUMBER: 251370977
BUSINESS ADDRESS:
STREET 1: 174 NAUSSAU STREEET
STREET 2: SUITE 3000
CITY: PRINCETON
STATE: NJ
ZIP: 08542
BUSINESS PHONE: 609-228-1231
MAIL ADDRESS:
STREET 1: 174 NAUSSAU STREEET
STREET 2: SUITE 3000
CITY: PRINCETON
STATE: NJ
ZIP: 08542
D/A
1
primary_doc.xml
X0708
D/A
LIVE
0002012879
SOSV IRELAND BIOMANUFACTURING FUND LP
174 NAUSSAU STREEET
SUITE 3000
PRINCETON
NJ
NEW JERSEY
08542
609-228-1231
DELAWARE
None
None
Limited Partnership
true
2024
GENERAL PARTNER
SOSV IRELAND BIOMANUFACTURING FUND GP LLC
174 NASSAU STREET, SUITE 3000
PRINCETON
NJ
NEW JERSEY
08542
Promoter
GENERAL PARTNER OF THE ISSUER
SEAN
O'SULLIVAN
174 NASSAU STREET, SUITE 3000
PRINCETON
NJ
NEW JERSEY
08542
Promoter
MANAGING MEMBER OF THE GENERAL PARTNER OF THE ISSUER
Pooled Investment Fund
Venture Capital Fund
false
Decline to Disclose
- 06b
- 3C
- 3C.1
- 3C.7
true
0002012879-24-000001
2024-03-27
true
true
false
0
Indefinite
20800000
Indefinite
false
4
0
0
0
true
THE ISSUER'S GENERAL PARTNER, OR AN AFFILIATE OF THE ISSUER'S GENERAL PARTNER, MAY BE ENTITLED TO RECEIVE A MANAGEMENT FEE IN ACCORDANCE WITH THE ISSUER'S GOVERNING DOCUMENTATION, AS AMENDED FROM TIME TO TIME.
false
SOSV IRELAND BIOMANUFACTURING FUND LP
/S/ SEAN O'SULLIVAN
SEAN O'SULLIVAN
MANAGING MEMBER OF THE GENERAL PARTNER OF THE ISSUER
2025-10-02